Prosus has signed a three-year Global Partnership Agreement with Amazon Web Services to accelerate AI adoption across its portfolio companies in Latin America, Europe, and India, enabling businesses ...
European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire ...
AIxCrypto Holdings today announced it is entering a new phase of accelerated execution. As the Company's "AI × Crypto × RWA" strategy delivers substantial progress across product development, user ...
The MarketWatch News Department was not involved in the creation of this content. NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orphai Therapeutics Inc. ("Orphai"), a clinical-stage ...
The memory giant projected an operating profit of 20 trillion won for the final quarter of 2025. That came as memory prices surged an estimated 40%-50% in the quarter of 2025. Samsung still lags SK ...
Hamza is a gaming enthusiast and a Writing Specialist from Pakistan. A firm believer in Keyboard/Mouse supremacy, he will play Tekken with WASD if you let him. He has been writing about games since ...
PRINCETON, N.J., Dec. 17, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Hosted on MSN
Disney Marvel Studios phase 4 CinemaCon presentation | Full breakdown of what to expect
DISNEY MARVEL STUDIOS PHASE 4 CinemaCon Presentation | Full Breakdown Of What To Expect | WandaVision, The Eternals Footage, Shang-Chi, Black Widow, Doctor Strange 2, X-men, New Mutants, Blade, ...
The biggest stories of the day delivered to your inbox.
– NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE(-) level) by independent review committee – – In four out of five pending patients, MRD negativity in bone marrow ...
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results